Harry Boxer
The Technical Trader
The stock market indices had a tough session to start the week, down across the board. The day started out with a pop to the upside, and then they immediately sold off in a 3-wave decline to mid-session. They bounced around, and held the lows on the Nasdaq 100, while the S&P 500 made a slightly higher low, and then they rallied to early afternoon, snapping back about two-thirds of the losses, but they couldn't maintain that. When resistance thwarted the advance, they then rolled over again, the S&P 500 closing right on its low, but the Nasdaq 100 closed about 10 points off its low.
Net on the day, the Dow was down 78.57 at 17,719.32. The S&P 500 was down 9.70 to 2080.41, the exact print low. The Nasdaq 100 was down 15.96 to 4664.51.
Advance-declines were 417 issues negative on New York Stock Exchange and less than 180, or so, issues negative on Nasdaq. Up/down volume was decidedly negative by 3 to 2 on New York, with total volume of 4 billion shares. Nasdaq traded 1.2 billion shares, and had a 4 to 3 positive volume ratio.
TheTechTrader.com board was very mixed. Priceline.com (PCLN) was the lone standout in the Nasdaq 100 stocks, up 3.86 to 1248.85, and Apple Inc. (AAPL) managed to gain 54 cents to 118.30 on Black Friday sales, but Google Inc. (GOOG) was down 7.66 to 742.60, Amazon.com Inc. (AMZN) down 8.46 to 664.80, and Netflix, Inc. (NFLX) down 2.11 to 123.33.
Tesla Motors, Inc. (TSLA) lost 1.35 to 230.26, but Baidu, Inc. (BIDU) had a big day today, closing up 12.39 to 217.97, or 6%, on 20 million shares traded. Many of the Chinese stocks were up today. However, BIDU was trading three points lower in after hours.
Stocks on the downside proved biotech's did not have a good day. Cellectis S.A. (CLLS) was down 1.03 to 33.09, NewLink Genetics Corporation (NLNK) down 1.82 to 36.60, Prothena Corporation (PRTA) down 4.77 to 70.54 in the biotech sector.
Checking the TheTechTrader.com percent-gain leaderboard, Anavex Life Sciences Corp. (AVXL) advanced 99 cents to 6.99, or 16 1/2%, on 20 million shares, and traded as high as 8.14 at one point in the day. Geron Corporation (GERN) climbed 61 cents to 5.10, or 14%, on 9.4 million shares. Novavax, Inc. (NVAX) thrust 76 cents to 8.56, or 10%, on 8.1 million shares.
Harvard Apparatus Regenerative Technology, Inc. (HART) gained 1.05 to 3.25, or 48%, on 18 million shares, 2800% increase in volume. Hi-Crush Partners LP (HCLP) nearly ran straight up to 8.40, pulled back, but still closed up 1.47 to 7.75, or 23%. Oramed Pharmaceuticals Inc. (ORMP) nearly opened at the 10.74 high before stair-stepping its way down to 9.10, up 1.35, or 17%, on 3 million shares.
Other gainers of note included Axovant Sciences Ltd. (AXON), up 1.70 to 18.98, ITC Holdings Corp. (ITC) up 3.13 to 36.88, Nevro Corp. (NVRO) 5.52 to 60.38, Ambarella, Inc. (AMBA) 4.34 to 62.81, Dynavax Technologies Corporation (DVAX) 1.66 to 27.89, and Cirrus Logic Inc. (CRUS) 2.72 to 33.06.
Stepping back and reviewing the hourly chart patterns, the indices were up right at the opening, they sold off to midday, rallied in early afternoon, but sold back off into the close to finish with the blue chips near the session lows.
Let's see how it goes tomorrow.
Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
EUR/USD stays below 1.0700 as focus shifts to Fed policy decisions
EUR/USD stays in its daily range below 1.0700 following the mixed macroeconomic data releases from the US. Private sector rose more than expected in April, while the ISM Manufacturing PMI fell below 50. Fed will announce monetary policy decisions next.
GBP/USD holds steady below 1.2500 ahead of Fed
GBP/USD is off the lows but stays flatlined below 1.2500 on Wednesday. The US Dollar stays resilient against its rivals despite mixed data releases and doesn't allow the pair to stage a rebound ahead of the Fed's policy decisions.
Gold rebounds above $2,300 after US data, eyes on Fed policy decision
Gold gained traction and recovered above $2,300 in the American session on Wednesday. The benchmark 10-year US Treasury bond yield turned negative on the day after US data, helping XAU/USD push higher ahead of Fed policy announcements.
A new stage of Bitcoin's decline
Bitcoin's closing price on Tuesday became the lowest since late February, confirming the downward trend and falling under March and April support and the psychologically important round level.
US Federal Reserve Decision Preview: Markets look for clues about interest rate cut timing
The Federal Reserve is widely anticipated to keep interest rates unchanged. Fed Chairman Powell’s remarks could provide important clues about the timing of the policy pivot.